Search Within

Lilian M Reich

Formats
  1. Meeting Abstract (49)
  2. Journal Article (45)
  3. Conference Paper (4)
  4. Book Section (1)
Groups
  1. Department of Medicine (99)
  2. Hematologic Malignancies, Division of (99)
  3. Center for Hematologic Malignancies (47)
  4. Sloan Kettering Institute Faculty (31)
  5. Solid Tumor Oncology Division (31)
  6. Survivorship Research (28)

More Groups

People
  1. Stephen Nimer (26)
  2. Raymond Comenzo (22)
  3. Larry Norton (21)
  4. Hani Hassoun (20)
  5. John Crown (19)
  6. Martin Fleisher (17)

More People

Years
  1. 2017 (1)
  2. 2016 (2)
  3. 2015 (1)
  4. 2014 (2)
  5. 2013 (5)
  6. 2012 (1)

More Years

Publications
  1. Blood (39)
  2. Bone Marrow Transplantation (11)
  3. Journal of Clinical Oncology (9)
  4. Transfusion (4)
  5. Artificial Organs (3)
  6. Biology of Blood and Marrow Transplantation (3)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Nature Publishing Group (13)
  3. American Society of Clinical Oncology (9)
  4. Elsevier Inc. (7)
  5. American Association for Cancer Research (5)
  6. Blackwell Publishing (4)

More Publishers

Results (99)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: Results of a phase II trial
    Journal Article

    Cohen, A. D.; Zhou, P.; Chou, J.; Teruya-Feldstein, J.; Reich, L.; Hassoun, H.; Levine, B.; Filippa, D. A.; Riedel, E.; Kewalramani, T.; more...
    British Journal of Haematology (2007)

    Fulltext@MSK | Save
  • Mobilization of blood stem cells with G-CSF in systemic light-chain amyloidosis: Dominant organ involvement significantly affects stem cell collection
    Meeting Abstract

    Comenzo, R.; Hassoun, H.; Reich, L.; Collins, N.; Nuta, A.; Chen, X. S.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Risk-adapted melphalan (MEL) with stem cell transplant (SCT) and adjuvant dexamethasone (D)+/- thalidomide (T) for AL patients achieves low treatment-related mortality (TRM) and high hematologic response rates
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
    Amyloid (2006)

    Fulltext@MSK | Save
  • Topotecan, thiotepa, and carboplatin for neuroblastoma: Failure to prevent relapse in the central nervous system
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Kernan, N. A.; Reich, L. M.; Danis, K.; Cheung, N. K. V.
    Bone Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
    Journal Article

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Zimman, R.; Drake, L.; Riedel, E. R.; Hedvat, C. V.; more...
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Results of a phase I/II trial adding carmustine (300mg/m 2) to melphalan (200mg/m 2) in multiple myeloma patients undergoing autologous stem cell transplantation
    Journal Article

    Comenzo, R. L.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Dhodapkar, M.; Reich, L.; Teruya-Feldstein, J.; Fleisher, M.; Filippa, D.; Nimer, S. D.
    Leukemia (2006)

    Fulltext@MSK | Save
  • Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts)
    Meeting Abstract

    Kondagunta, G. V.; Bacik, J.; Bajorin, D. F.; Reich, L.; Sheinfeld, J.; Bains, M.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Adjuvant dexamethasone (D)+/- thalidomide (T) improves hematologic and organ responses after risk-adapted high-dose melphalan with autologous stem cell transplant (SCT) for patients with systemic AL amyloidosis (AL)
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L.
    Blood (2005)

    Fulltext@MSK | Save
  • Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL)
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save